We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Ultra-Fast Real-Time PCR Platform Could Revolutionize POC Molecular Diagnostics

By LabMedica International staff writers
Posted on 08 Nov 2022

An ultra-fast point-of-care real-time PCR platform for infectious disease diagnostics that is currently under development will be able to deliver results within five minutes at a cost equivalent to antigen tests currently available in the market. More...

Using proprietary technologies, LEX Diagnostics (Melbourn, UK) is developing a platform that could revolutionize point-of-care molecular diagnostics with a step change in speed, sensitivity and cost. The LEX System being developed by LEX Diagnostics aims to deliver true-PCR insights to clinicians at the time they are most valuable, meaning an answer in 5-7 minutes. Amplifying the genetic material over tens of thermal cycles is the bottleneck for conventional PCR systems. LEX’s amplification chambers can be heated or cooled in seconds. The company’s IP enables ultrafast thermocycling without the need for an expensive, unreliable Peltier cooler. This enables a compact, robust reader with a low cost of goods.

RT-PCR is the gold standard for the diagnosis of viral infectious disease. LEX has shown that its platform amplifies viruses with lab-standard sensitivity and selectivity. LEX’s IP protects a cartridge design that can be made from industry standard materials developed by experienced engineers to be within standard process tolerances. The LEX System is compact enough to fit on the bench of the smallest physician’s office lab and simple enough to be used by the newest nurse or the oldest doctor in the practice. It will deliver results quickly enough to support the busiest urgent care yet is affordable enough for the smallest rural pharmacy.

Related Links:
LEX Diagnostics 


New
Gold Member
Thyroid-Stimulating Hormone Test
ULTRA-TSH
Verification Panels for Assay Development & QC
Seroconversion Panels
New
STI Test
RIDA GENE STI Mycoplasma Panel
New
PBC Assay
Primary Biliary Cholangitis Assays
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: A biomarker discovery pipeline has shown promise as a noninvasive method of diagnosing CRC (Photo courtesy of NCI Center for Cancer Research)

Machine Learning Tool Enables Noninvasive Diagnosis and Monitoring of Colorectal Cancer

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States when considering both genders. Colonoscopy remains the gold standard for CRC diagnosis, but it is invasive,... Read more

Technology

view channel
Image: Scanning electron microscopy images showing 3D micro-printed Limacon-shaped whispering-gallery-mode microcavities with different amounts of deformation (Photo courtesy of A. Ping Zhang/PolyU)

Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis

Optical whispering-gallery-mode microlaser sensors function by trapping light within tiny microcavities. When target molecules bind to the cavity, they induce subtle changes in the laser’s frequency, allowing... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.